Viriones de AAV con inmunorreactividad reducida y usos de los mismos
Uso de una proteína de la cápside de virus adeno-asociado (AAV) mutado, en un virión de AAV recombinante, para reducir la inmunorreactividad del virión en comparación con el correspondiente virión de tipo salvaje, en donde dicha proteína de la cápside de AAV mutado comprende una sustitución del amin...
Gespeichert in:
| Hauptverfasser: | , , , |
|---|---|
| Format: | Patent |
| Sprache: | spa |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | Surosky, Richard T Arbetman, Alejandra Elena Colosi, Peter Lochrie, Michael A |
| description | Uso de una proteína de la cápside de virus adeno-asociado (AAV) mutado, en un virión de AAV recombinante, para reducir la inmunorreactividad del virión en comparación con el correspondiente virión de tipo salvaje, en donde dicha proteína de la cápside de AAV mutado comprende una sustitución del aminoácido que se produce en la posición correspondiente a la posición 334 de la proteína de la cápside VP2 de AAV-2.
Methods of making and using recombinant AAV virions with decreased immunoreactivity are described. The recombinant AAV virions include mutated capsid proteins or are derived from non-primate mammalian AAV serotypes and isolates that display decreased immunoreactivity relative to AAV-2. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_ES2627913TT3</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>ES2627913TT3</sourcerecordid><originalsourceid>FETCH-epo_espacenet_ES2627913TT33</originalsourceid><addsrcrecordid>eNrjZHAJyyzKzM9LLVZISVVwdAxTSM7PU8jMyy3Nyy8qSk1MLsksy0xJTFEoSk0pTQayFCoVSovzwapzgFRuZnFufjEPA2taYk5xKi-U5mZQdHMNcfbQTS3Ij08tLkhMTs1LLYl3DTYyMzK3NDQOCTE2JkYNAIJrMtQ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Viriones de AAV con inmunorreactividad reducida y usos de los mismos</title><source>esp@cenet</source><creator>Surosky, Richard T ; Arbetman, Alejandra Elena ; Colosi, Peter ; Lochrie, Michael A</creator><creatorcontrib>Surosky, Richard T ; Arbetman, Alejandra Elena ; Colosi, Peter ; Lochrie, Michael A</creatorcontrib><description>Uso de una proteína de la cápside de virus adeno-asociado (AAV) mutado, en un virión de AAV recombinante, para reducir la inmunorreactividad del virión en comparación con el correspondiente virión de tipo salvaje, en donde dicha proteína de la cápside de AAV mutado comprende una sustitución del aminoácido que se produce en la posición correspondiente a la posición 334 de la proteína de la cápside VP2 de AAV-2.
Methods of making and using recombinant AAV virions with decreased immunoreactivity are described. The recombinant AAV virions include mutated capsid proteins or are derived from non-primate mammalian AAV serotypes and isolates that display decreased immunoreactivity relative to AAV-2.</description><language>spa</language><subject>BEER ; BIOCHEMISTRY ; CHEMISTRY ; COMPOSITIONS THEREOF ; CULTURE MEDIA ; ENZYMOLOGY ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; MICROBIOLOGY ; MICROORGANISMS OR ENZYMES ; MUTATION OR GENETIC ENGINEERING ; ORGANIC CHEMISTRY ; PEPTIDES ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS ; SPIRITS ; VINEGAR ; WINE</subject><creationdate>2017</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20170801&DB=EPODOC&CC=ES&NR=2627913T3$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,777,882,25545,76296</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20170801&DB=EPODOC&CC=ES&NR=2627913T3$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>Surosky, Richard T</creatorcontrib><creatorcontrib>Arbetman, Alejandra Elena</creatorcontrib><creatorcontrib>Colosi, Peter</creatorcontrib><creatorcontrib>Lochrie, Michael A</creatorcontrib><title>Viriones de AAV con inmunorreactividad reducida y usos de los mismos</title><description>Uso de una proteína de la cápside de virus adeno-asociado (AAV) mutado, en un virión de AAV recombinante, para reducir la inmunorreactividad del virión en comparación con el correspondiente virión de tipo salvaje, en donde dicha proteína de la cápside de AAV mutado comprende una sustitución del aminoácido que se produce en la posición correspondiente a la posición 334 de la proteína de la cápside VP2 de AAV-2.
Methods of making and using recombinant AAV virions with decreased immunoreactivity are described. The recombinant AAV virions include mutated capsid proteins or are derived from non-primate mammalian AAV serotypes and isolates that display decreased immunoreactivity relative to AAV-2.</description><subject>BEER</subject><subject>BIOCHEMISTRY</subject><subject>CHEMISTRY</subject><subject>COMPOSITIONS THEREOF</subject><subject>CULTURE MEDIA</subject><subject>ENZYMOLOGY</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>MICROBIOLOGY</subject><subject>MICROORGANISMS OR ENZYMES</subject><subject>MUTATION OR GENETIC ENGINEERING</subject><subject>ORGANIC CHEMISTRY</subject><subject>PEPTIDES</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS</subject><subject>SPIRITS</subject><subject>VINEGAR</subject><subject>WINE</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2017</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZHAJyyzKzM9LLVZISVVwdAxTSM7PU8jMyy3Nyy8qSk1MLsksy0xJTFEoSk0pTQayFCoVSovzwapzgFRuZnFufjEPA2taYk5xKi-U5mZQdHMNcfbQTS3Ij08tLkhMTs1LLYl3DTYyMzK3NDQOCTE2JkYNAIJrMtQ</recordid><startdate>20170801</startdate><enddate>20170801</enddate><creator>Surosky, Richard T</creator><creator>Arbetman, Alejandra Elena</creator><creator>Colosi, Peter</creator><creator>Lochrie, Michael A</creator><scope>EVB</scope></search><sort><creationdate>20170801</creationdate><title>Viriones de AAV con inmunorreactividad reducida y usos de los mismos</title><author>Surosky, Richard T ; Arbetman, Alejandra Elena ; Colosi, Peter ; Lochrie, Michael A</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_ES2627913TT33</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>spa</language><creationdate>2017</creationdate><topic>BEER</topic><topic>BIOCHEMISTRY</topic><topic>CHEMISTRY</topic><topic>COMPOSITIONS THEREOF</topic><topic>CULTURE MEDIA</topic><topic>ENZYMOLOGY</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>MICROBIOLOGY</topic><topic>MICROORGANISMS OR ENZYMES</topic><topic>MUTATION OR GENETIC ENGINEERING</topic><topic>ORGANIC CHEMISTRY</topic><topic>PEPTIDES</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS</topic><topic>SPIRITS</topic><topic>VINEGAR</topic><topic>WINE</topic><toplevel>online_resources</toplevel><creatorcontrib>Surosky, Richard T</creatorcontrib><creatorcontrib>Arbetman, Alejandra Elena</creatorcontrib><creatorcontrib>Colosi, Peter</creatorcontrib><creatorcontrib>Lochrie, Michael A</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>Surosky, Richard T</au><au>Arbetman, Alejandra Elena</au><au>Colosi, Peter</au><au>Lochrie, Michael A</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Viriones de AAV con inmunorreactividad reducida y usos de los mismos</title><date>2017-08-01</date><risdate>2017</risdate><abstract>Uso de una proteína de la cápside de virus adeno-asociado (AAV) mutado, en un virión de AAV recombinante, para reducir la inmunorreactividad del virión en comparación con el correspondiente virión de tipo salvaje, en donde dicha proteína de la cápside de AAV mutado comprende una sustitución del aminoácido que se produce en la posición correspondiente a la posición 334 de la proteína de la cápside VP2 de AAV-2.
Methods of making and using recombinant AAV virions with decreased immunoreactivity are described. The recombinant AAV virions include mutated capsid proteins or are derived from non-primate mammalian AAV serotypes and isolates that display decreased immunoreactivity relative to AAV-2.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | spa |
| recordid | cdi_epo_espacenet_ES2627913TT3 |
| source | esp@cenet |
| subjects | BEER BIOCHEMISTRY CHEMISTRY COMPOSITIONS THEREOF CULTURE MEDIA ENZYMOLOGY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY MICROBIOLOGY MICROORGANISMS OR ENZYMES MUTATION OR GENETIC ENGINEERING ORGANIC CHEMISTRY PEPTIDES PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS SPIRITS VINEGAR WINE |
| title | Viriones de AAV con inmunorreactividad reducida y usos de los mismos |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-20T16%3A22%3A16IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=Surosky,%20Richard%20T&rft.date=2017-08-01&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EES2627913TT3%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |